Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Wai Hong Wilson Tang, MD
Healthcare Professional Research Director
Department of Cardiovascular Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
W. H. Wilson Tang, MD, is Research Director, and staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic. Dr. Tang is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is also associated with Cleveland Clinic Amyloidosis Center.
Dr. Tang graduated magna cum laude with a Bachelor of Science degree in neural sciences from Brown University in Rhode Island, where he matriculated at Jesus College, Cambridge University, in England for an honorary one-year period of study in molecular medicine. Dr. Tang received his medical degree from Harvard Medical School and completed his internship and residency in internal medicine, and a research fellowship in heart failure at Stanford University Medical Center. This was followed by clinical cardiology fellowship training at the Cleveland Clinic, and an advanced clinical fellowship in heart failure and cardiac transplantation.
He is board-certified in internal medicine, cardiovascular medicine, and advanced heart failure and transplant cardiology. He currently serves as a member of the Board of Directors of the Heart Failure Society of America.
Representative Publications:
myBinderRelated Content
-
Eva Medvedova, MDEva Medvedova is an Assistant Professor ...
-
Maria M. Picken, MD, FASCP, FCAP, FASNDr. Picken received her MD and PhD degre...
-
Randall Starling, MD, MPHRandall C. Starling, MD, MPH, FACC, FESC...
-
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid CardiomyopathyBackground: Tafamidis is approved in ma...
-
Improving Strategies for the Diagnosis of Cardiac AmyloidosisAmyloidosis refers to a group of rare bu...
-
Ronald G. Schwartz, MD, MSDr. Schwartz is a Professor of Medicin...
-
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid CardiomyopathyPfizer Inc. announced today that the US ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
